UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Risk-sharing agreements back up economic feasibility review’
An expert said expanding risk-sharing agreements (RSA) and introducing a po...
by Kim Yun-mi
|
2019-05-22 14:46
라인
Regulator inspecting Kolon TissuGene in US this week
A delegation of the Ministry of Food and Drug Safety left for the U.S. on S...
by Lee Hye-seon
|
2019-05-20 14:22
라인
Expat students worry about hefty medical insurance fees from mid-July
Foreign students who stay in Korea for more than six months from July must ...
by Lee Han-soo
|
2019-05-14 14:17
라인
State-funded smoking cessation program may face overhaul
The government is expected to revise its smoking cessation support programs...
by Kwak Sung-sun
|
2019-05-09 15:19
라인
‘Invossa scandal might be more far-reaching’
An activist physician claimed that Invossa-K, recently suspended gene thera...
by Jeong Sae-im
|
2019-04-26 18:08
라인
Korea succeeds in reducing inflow of foreign tuberculosis patients
Korea has achieved positive results from the measures it implemented to red...
by Lee Han-soo
|
2019-04-26 17:58
라인
Korea to cooperate on healthcare with 3 Central Asian countries
The Ministry of Health and Welfare announced that it plans to work closely ...
by Lee Han-soo
|
2019-04-24 17:10
라인
‘Consider N. Korea’s adoption of health insurance in inter-Korean exchange’
South Korea should consider that North Korea might introduce a national hea...
by Kwak Sung-sun
|
2019-04-24 14:28
라인
Regulator suspends Eutilex’ trial on cell therapy
The Ministry of Food and Drug Safety said it recently ordered Eutilex to su...
by Jeong Sae-im
|
2019-04-23 15:13
라인
IVI-led consortium wins Fleming Fund's grant
An international consortium led by the International Vaccine Institute (IVI...
by Lee Han-soo
|
2019-04-18 11:15
라인
THAAD backlash almost over: Chinese patients to Korea up 18 %
The number of Chinese patients visiting Korea rebounded in 2018, signaling ...
by Kwak Sung-sun
|
2019-04-17 16:00
라인
HIRA generates ₩35 billion worth economic value through international biz
The Health Insurance Review and Assessment Service (HIRA) said it has creat...
by Song Soo-youn
|
2019-04-16 16:19
라인
Anti-abortion law ruled unconstitutional in Korea
The Constitutional Court on Thursday ruled that the provisions governing th...
by Choi Gwang-seok
|
2019-04-11 18:02
라인
Generic drug approvals doubled amid imminent scrap of consigned bioequivalence tests
After the Ministry of Food and Drug Safety announced that it would graduall...
by Lee Hye-seon
|
2019-04-11 16:00
라인
Regulator to probe Kolon with all possible scenarios over Invossa debacle
The Ministry of Food and Drug Safety said it would investigate the safety i...
by Lee Hye-seon
|
2019-04-10 15:37
라인
Korea to spend ₩480 billion for pharma, biotech sector
The government said it would spend 477.9 billion won ($419.3 million) to he...
by Kwak Sung-sun
|
2019-04-10 15:32
라인
Bill supporting high-tech biopharmaceuticals blocked amid Invossa setback
A bill that supports advanced generative medicine and high-tech biopharmace...
by Kwak Sung-sun
|
2019-04-05 16:15
라인
Bodybuilders booked for smuggling anabolic steroids
The regulator has caught 12 bodybuilders and trainers who smuggled muscle-e...
by Lee Hye-seon
|
2019-04-05 12:23
라인
Anticipation grows for bill to support advanced biopharmaceuticals
A bill to support advanced regenerative medicine and high-tech biopharmaceu...
by Lee Hye-seon
|
2019-04-04 15:25
라인
‘Regulator responsible for suspension of Invossa’
A civic group said the Ministry of Food and Drug Safety should be held acco...
by Song Soo-youn
|
2019-04-02 15:58
-
이전
21
22
23
24
25
26
27
28
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top